To Prevent Shortages, US FDA Wants Sponsor To Provide Notifications Of Demand Spike

empty blister pack
The FDA monitors data to try to anticipate demand spikes that could cause a drug shortage • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

More from Regulation

More from Policy & Regulation